Related Experiment Video
Updated: Sep 20, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Disruption of cardiac Ena-VASP protein localization in intercalated disks causes dilated cardiomyopathy
Martin Eigenthaler1, Stefan Engelhardt, Birgitta Schinke
1Institut für Klinische Biochemie und Pathobiochemie, Universität Würzburg, Germany.
Abstract:
Vasodilator-stimulated phosphoprotein (VASP) and mammalian enabled (Mena) are actin cytoskeleton and signaling modulators. Ena-VASP proteins share an identical domain organization with an NH2-terminal Ena VASP homology (EVH1) domain, which mediates the binding of these proteins to FPPPP-motif containing partners such as zyxin and vinculin. VASP and Mena are abundantly expressed in the heart. However, previous studies showed that disruption by gene targeting of VASP or Mena genes in mice did not reveal any cardiac phenotype, whereas mice lacking both VASP and Mena died during embryonic development. To determine the in vivo function of Ena-VASP proteins in the heart, we used a dominant negative strategy with cardiac-specific expression of the VASP-EVH1 domain. Transgenic mice with cardiac myocyte-restricted, alpha-myosin heavy chain promoter-directed expression of the VASP-EVH1 domain were generated. Overexpression of the EVH1 domain resulted in specific displacement of both VASP and Mena from cardiac intercalated disks. VASP-EVH1 transgenic mice developed dilated cardiomyopathy with myocyte hypertrophy and bradycardia, which resulted in early postnatal lethality in mice with high levels of transgene expression. The results demonstrate that Ena-VASP proteins may play an important role in intercalated disk function at the interface between cardiac myocytes.
Insights
Ena-VASP proteins are crucial for heart function. Inhibiting them with the VASP-EVH1 domain in mice caused dilated cardiomyopathy and early death, highlighting their role in cardiac intercalated disks.
Area of Science:
- Cardiovascular Biology
- Molecular Cell Biology
- Biochemistry
Background:
- Vasodilator-stimulated phosphoprotein (VASP) and mammalian enabled (Mena) are key regulators of the actin cytoskeleton and signaling pathways.
- Ena-VASP proteins, characterized by their EVH1 domain, interact with partners like zyxin and vinculin.
- While VASP and Mena are abundant in the heart, their specific roles were unclear from single-gene knockout studies.
Purpose of the Study:
- To investigate the in vivo function of Ena-VASP proteins in the heart.
- To elucidate the role of Ena-VASP proteins in cardiac intercalated disk function.
Main Methods:
- Generation of transgenic mice with cardiac-specific expression of the VASP-EVH1 domain using the alpha-myosin heavy chain promoter.
- Utilizing a dominant-negative strategy to displace endogenous VASP and Mena proteins from cardiac structures.
- Analysis of cardiac phenotype, including myocyte structure, heart rate, and survival.
Main Results:
- Cardiac-specific overexpression of the VASP-EVH1 domain successfully displaced VASP and Mena from intercalated disks.
- Transgenic mice developed dilated cardiomyopathy, characterized by myocyte hypertrophy and bradycardia.
- High levels of transgene expression led to early postnatal lethality in affected mice.
Conclusions:
- Ena-VASP proteins are essential for maintaining normal cardiac structure and function.
- These proteins play a critical role in the integrity and function of cardiac intercalated disks.
- Disruption of Ena-VASP function leads to severe cardiac pathology and reduced survival.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy IV: Restrictive Cardiomyopathy
Mitral Valve Prolapse I: Introduction
